| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $146,241,967 ) (Continued on the next page) |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322 | DEKALB | USA | R01NS137434 | Mechanisms of chimeric DPR production and toxicity in c9ALS/FTD | 000 | 3 | NIH | 4/21/2026 | $620,736 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01NS146992 | Understanding the contribution of BCL11A to neuron function and neurological disease | 000 | 1 | NIH | 1/27/2026 | $575,485 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R35GM148416 | Genetic Dissection of Signaling and Cilia | 001 | 4 | NIH | 1/14/2026 | $82,045 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R35GM148416 | Genetic Dissection of Signaling and Cilia | 000 | 4 | NIH | 1/7/2026 | $405,361 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322 | DEKALB | USA | R35GM158404 | Mechanisms of RNA localization and centrosome regulation | 000 | 2 | NIH | 4/27/2026 | $421,104 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322 | DEKALB | USA | R35GM156739 | Lipoprotein trafficking to the bacterial outer membrane | 001 | 2 | NIH | 3/11/2026 | $43,461 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R35GM156739 | Lipoprotein trafficking to the bacterial outer membrane | 000 | 2 | NIH | 12/12/2025 | $391,145 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322 | DEKALB | USA | R35GM158221 | Novel Bowl-shaped Catalysts for Selective C-H Functionalization | 000 | 2 | NIH | 5/12/2026 | $371,304 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322 | DEKALB | USA | R35GM153472 | DNA nanodevices for molecular interrogation and regulation of lymphocytes in adaptive immune system | 000 | 3 | NIH | 4/7/2026 | $391,250 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322 | DEKALB | USA | R35GM162385 | Dietary Chelators in Metal Homeostasis | 000 | 1 | NIH | 4/1/2026 | $430,375 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322 | DEKALB | USA | R25DK101390 | Summer Undergraduate Program in Emory Renal Research (SUPERR) | 000 | 13 | NIH | 3/27/2026 | $120,183 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322 | DEKALB | USA | R35GM143050 | MULTICOMPONENT MECHANOCHEMICAL REGULATION OF ACTIN FILAMENT END DYNAMICS | 002 | 6 | NIH | 4/29/2026 | $458,196 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R25GM156529 | Enhancing Access for Successful Evaluation (EASE) Learning Experience | 000 | 2 | NIH | 2/20/2026 | $104,541 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322 | DEKALB | USA | R21NS142860 | GPR123 Activation by Steroid Ligands | 000 | 2 | NIH | 3/23/2026 | $195,625 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R21NS142817 | Neuromodulation of somato-sympathetic postganglionic activity after SCI | 000 | 1 | NIH | 1/26/2026 | $234,750 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322 | DEKALB | USA | R21NS142808 | Determining the specific hemodynamics related to clot formation and subsequent stroke in subjects with carotid webs | 000 | 2 | NIH | 3/23/2026 | $242,495 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322 | DEKALB | USA | R21NS145127 | Exploring the contribution of extracellular vesicles to epileptogenesis in TLE and DS | 000 | 1 | NIH | 5/5/2026 | $420,142 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322 | DEKALB | USA | R21NS146918 | NMDA receptor regulation of rapid scaling and spinal excitability in fragile X syndrome. | 000 | 1 | NIH | 5/12/2026 | $234,750 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R21MH142870 | Precision Targeting of Hippocampal Subfields with AAVs | 000 | 1 | NIH | 3/13/2026 | $430,375 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R21MH139049 | Integrating Loneliness and Social Isolation Insights into Late-Life Suicide Risk Prediction Through the Digital Phenotyping of Electronic Health Records | 000 | 2 | NIH | 2/18/2026 | $199,024 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322 | DEKALB | USA | R24ES028528 | The Michigan PBB Cohort: A unique, highly exposed community followed for 50 years and three generations | 000 | 8 | NIH | 4/29/2026 | $366,591 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R24ES028507 | Enriching the Rhode Island Child Health Study | 000 | 9 | NIH | 2/13/2026 | $494,162 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R21TW012879 | GROW: Adapting and Enhancing Group-based Prenatal Care to Support Healthy Gestational Weight Gain for HIV-affected Women | 002 | 1 | NIH | 2/23/2026 | $0 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R21TW012879 | GROW: Adapting and Enhancing Group-based Prenatal Care to Support Healthy Gestational Weight Gain for HIV-affected Women | 001 | 1 | NIH | 2/20/2026 | $81,004 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R21TW012879 | GROW: Adapting and Enhancing Group-based Prenatal Care to Support Healthy Gestational Weight Gain for HIV-affected Women | 000 | 1 | NIH | 2/13/2026 | $92,281 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322 | DEKALB | USA | R25AI175048 | INfectious Diseases Summer Program Integrating Research at Emory (INSPIRE) | 001 | 3 | NIH | 4/24/2026 | $378,762 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | U01AI141993 | Molecular Mechanisms of Human Long-lived Plasma Cell Generation in the Bone Marrow and Spleen | 000 | 8 | NIH | 1/14/2026 | $699,855 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322 | DEKALB | USA | R61NS130128 | Subtype-Selective Metabotropic Glutamate Receptor PET Ligands | 000 | 3 | NIH | 4/21/2026 | $767,744 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322 | DEKALB | USA | R61AI197036 | Novel Long-Acting HBV Capsid Assembly Modulators | 000 | 1 | NIH | 4/9/2026 | $954,603 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322 | DEKALB | USA | R61MH138733 | PREVENT study: Promoting resilience via early neurostimulation after trauma | 000 | 1 | NIH | 3/16/2026 | $1,229,954 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322 | DEKALB | USA | R35NS111619 | Glutamate receptors and human neurological disease | 000 | 8 | NIH | 4/17/2026 | $992,303 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R56AG097727 | Reproductive events, menopause and biological aging among Latina women | 000 | 1 | NIH | 1/28/2026 | $391,250 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R50MH141887 | A Foot in Each World: Bridging the Divide Between Clinical Research and the Mobile Apps That Support It | 000 | 1 | NIH | 3/5/2026 | $156,500 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R37AI076119 | Ultrapotent Inhibitors of Wild-type and Multi-drug Resistant HIV | 000 | 18 | NIH | 1/9/2026 | $612,503 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R37AI157862 | Enhanced latency reversal and reservoir clearance in macaques | 000 | 6 | NIH | 2/27/2026 | $909,998 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R37AI150556 | Determinants of reservoir contraction and expansion in vivo, ex vivo, and in vitro | 000 | 7 | NIH | 2/13/2026 | $648,378 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322 | DEKALB | USA | R38HL167243 | Emory Pediatrics and Pathology Stimulating Access to Research in Residency (Emory-PP StARR). | 001 | 4 | NIH | 4/17/2026 | $8,360 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R37MH117103 | Integrated mechanisms for orbitofrontal cortical control of memory and choice | 000 | 8 | NIH | 1/13/2026 | $666,266 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322 | DEKALB | USA | R37CA296075 | Algorithm-enabled Patients Activated in Cancer care through Teams (A-PACT) toimprove goals of care communication for people with cancer | 000 | 2 | NIH | 4/27/2026 | $641,674 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322 | DEKALB | USA | R38HL167243 | Emory Pediatrics and Pathology Stimulating Access to Research in Residency (Emory-PP StARR). | 000 | 4 | NIH | 3/30/2026 | $409,623 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322 | DEKALB | USA | R37CA297078 | Targeting non-genetic and genetic mechanisms to overcome drug resistance in acute myeloid leukemia | 000 | 1 | NIH | 4/28/2026 | $639,859 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322 | DEKALB | USA | R35GM148217 | The Gut as a Target to Improve Outcomes in Sepsis | 001 | 4 | NIH | 3/16/2026 | $53,210 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R35GM148217 | The Gut as a Target to Improve Outcomes in Sepsis | 000 | 4 | NIH | 12/15/2025 | $478,890 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322 | DEKALB | USA | R35GM148416 | Genetic Dissection of Signaling and Cilia | 002 | 4 | NIH | 3/19/2026 | $45,040 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322 | DEKALB | USA | U01AI187057 | Influenza Modeling of Correlates of Protection for Optimal Immune Dynamics and Evolution. | 000 | 2 | NIH | 4/2/2026 | $1,171,832 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322 | DEKALB | USA | U01CA264039 | Improved whole-brain spectroscopic MRI for radiation therapy planning | 000 | 8 | NIH | 4/17/2026 | $621,200 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | T32GM095442 | Critical Care Training Program | 000 | 15 | NIH | 2/5/2026 | $3,000 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322 | DEKALB | USA | T32GM152344 | Biological Discovery through Chemical Innovation Training Program at Emory University | 000 | 3 | NIH | 5/11/2026 | $325,003 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | T32GM148391 | IMSD at Emory University | 000 | 4 | NIH | 1/30/2026 | $669,996 |
|
